We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Infectious mononucleosis complicated by transitory Epstein-Barr virus infection of T and natural killer cells

    Epstein-Barr virus (EBV) typically infects B cells in infectious mononucleosis (IM), but a rare case shows EBV infection in T cells. Seven cases of...

    Yanlin Zhang, JianLan **e, ... **aoGe Zhou in Journal of Hematopathology
    Article Open access 05 July 2024
  2. Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)

    Gastric cancer is the 5 th most common malignancy worldwide with only 36% of patients with metastatic disease surviving beyond 5 years. Despite...

    Matthew J. Hadfield, Howard Safran, ... Benedito A. Carneiro in Oncogene
    Article 29 January 2024
  3. Novel target and treatment agents for natural killer/T-cell lymphoma

    The rapidly increasing use of high-throughput screening had produced a plethora of expanding knowledge on the molecular basis of natural...

    **ao-Peng Tian, Yi Cao, ... Qing-Qing Cai in Journal of Hematology & Oncology
    Article Open access 22 July 2023
  4. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab

    Natural killer/T cell lymphoma (NKTCL) is a highly aggressive, heterogeneous non-Hodgkin lymphoma resulting from malignant proliferation of cytotoxic...

    Min Qing, Tianyuan Zhou, ... Raluca I. Verona in Annals of Hematology
    Article Open access 18 January 2024
  5. Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus

    Objective

    Numerous immune cell types, such as B and T lymphocytes, natural killer cells (NK), and NKT cells, are related to the pathogenesis of...

    Ning Chen, Yijun Dai, ... Qing Yan in Clinical Rheumatology
    Article 11 September 2023
  6. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies

    Natural killer (NK) cell belongs to innate lymphoid cell family that contributes to host immunosurveillance and defense without pre-immunization....

    Juanjuan Shang, Shunfeng Hu, **n Wang in Experimental Hematology & Oncology
    Article Open access 23 February 2024
  7. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus

    Objectives

    To evaluate the absolute numbers and frequencies of natural killer T-like (NKT-like) cells in systemic lupus erythematosus (SLE) and to...

    Sumei Tang, Yushu Wang, ... Yingni Li in Clinical Rheumatology
    Article 11 January 2023
  8. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells

    Hydroa vacciniforme lymphoproliferative disorder (HV-LPD) is a cutaneous variant of chronic active Epstein–Barr virus disease. We examined the...

    Yoji Hirai, Keiji Iwatsuki, ... Shin Morizane in International Journal of Hematology
    Article Open access 03 May 2023
  9. Chimeric antigen receptor engineered natural killer cells for cancer therapy

    Natural killer (NK) cells, a unique component of the innate immune system, are inherent killers of stressed and transformed cells. Based on their...

    Yalan Zhang, Weilin Zhou, ... Wei Wang in Experimental Hematology & Oncology
    Article Open access 10 August 2023
  10. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series

    Extranodal natural killer/T-cell lymphoma (ENKTL) with hepatosplenic involvement is rare, accounting for approximately 0.2% of ENKTL cases. The...

    Yue-Hua Zhang, Zheng Li, ... Li-Min Gao in Annals of Hematology
    Article 12 July 2023
  11. Extranodal natural killer/T cell lymphoma of the skeletal muscle

    This case report highlights a case of extranodal NK/T cell lymphoma initially misdiagnosed as myositis, emphasizing the appearance on both MRI and...

    Ettore di Gaeta, Floortje Verspoor, ... Robert Hemke in Skeletal Radiology
    Article Open access 20 April 2024
  12. Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects

    Purpose

    Cisplatin-based chemotherapy is now an important treatment for improving bladder cancer prognosis. However, challenges in clinical treatment...

    Zhu Wang, Zhan Yang, ... **aolu Wang in International Urology and Nephrology
    Article Open access 30 May 2023
  13. Diminished natural killer T-like cells correlates with aggravated primary Sjögren’s syndrome

    Objective

    To reveal the characteristics and potential role of natural killer T-like cells (NKT-like cells) in the pathogenesis of primary Sjögren’s...

    **nhua Zhou, Qingxiang Li, ... Yingni Li in Clinical Rheumatology
    Article 21 January 2022
  14. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma

    Natural killer/T‐cell lymphoma (NKTCL) is an aggressive and malignant condition with a high mortality rate. Prognostic factors may assist to evaluate...

    Yun Hui, Yingjun Gao, ... Hong Sang in Annals of Hematology
    Article 14 December 2023
  15. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma

    Natural killer T cell lymphoma (NKTCL) is highly aggressive, with advanced stage patients poorly responding to intensive chemotherapy. To explore...

    Jie **ong, Shu Cheng, ... Wei-Li Zhao in Signal Transduction and Targeted Therapy
    Article Open access 06 March 2024
  16. The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients

    Controlling nutritional status (CONUT) score as an original nutritional assessment tool can be used to assess the prognosis of patients with a...

    Shuo Zhang, Cai Sun, ... Wei Sang in Annals of Hematology
    Article 19 April 2023
  17. Myeloid-derived Suppressor Cells Activate Liver Natural Killer Cells in a Murine Model in Uveal Melanoma

    Objective

    Elevated myeloid-derived suppressor cells (MDSCs) in many malignancies are associated with the increased risk for metastases and poor...

    Yuan-yuan Wang, Shuang-ying Li, ... Zhi-qiang Han in Current Medical Science
    Article 17 October 2022
  18. Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma

    The treatment of natural killer/T-cell lymphoma (NKTCL) presents an onerous challenge, and a search for new therapeutic targets is urgently needed....

    Chen Gong, Jiazhuo Wu, ... Mingzhi Zhang in Annals of Hematology
    Article 27 July 2023
  19. Evolution of natural killer cell-targeted therapy for acute myeloid leukemia

    In hematologic oncology, acute myeloid leukemia (AML) presents a significant challenge due to its complex genetic landscape and resistance to...

    Yuta Kaito, Yoichi Imai in International Journal of Hematology
    Article 01 May 2024
  20. Natural killer cell immunotherapy in glioblastoma

    Glioblastoma (GBM) is one of the most difficult cancers to treat because GBM has the high therapeutic resistance. Recently, immunotherapies for GBM...

    Hamed Hosseinalizadeh, Mehryar Habibi Roudkenar, ... Tomoaki Sato in Discover Oncology
    Article Open access 28 October 2022
Did you find what you were looking for? Share feedback.